ACHN News Alert Achillion Pharmaceuticals (ACHN) 13.31 11/18/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Achillion Pharmaceuticals (ACHN) 13.31 $ACHN

Nasdaq stocks posting largest percentage increases
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ESCA: 12.90 (+0.14), IMDZ: 34.55 (-0.54), OLED: 28.12 (+1.16), FUEL: 17.54 (-0.24), CZR: 15.32 (-0.46), NTIC: 21.00 (+0.10), RESN: 7.94 (+0.86), OREX: 5.62 (+0.11), VBFC: 20.25 (+0.75), FLML: 13.20 (-0.21), ACHN: 13.31 (-0.01), RDI: 11.77 (-0.10), AMOT: 20.10 (+0.21), SUSQ: 13.10 (+0.06), RDIB: 11.84 (-0.16)

Profit taking sinks Achillion
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 12:48PM CST

ACHN: 13.31 (-0.01)

5 Momentum Stocks Currently on the Move with More Potential Upside
at The Street - Thu Nov 13, 11:34AM CST
Achillion, Groupon, Orexigen, Rackspace and TG Therapeutics have had strong recent moves and are showing no sign of slowing.
OREX: 5.62 (+0.11), RAX: 42.70 (-0.39), ACHN: 13.31 (-0.01), TGTX: 14.77 (+0.72), GRPN: 7.37 (-0.20)

Will Achillion Pharmaceuticals (ACHN) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:25AM CST
Will Achillion Pharmaceuticals (ACHN) Continue to Surge Higher?
ACHN: 13.31 (-0.01)

Achillion Pharmaceuticals: Still Bullish, But Taking Profits
Dr. Paul Nunzio DeSantis, Pharm.D - Seeking Alpha - Wed Nov 12, 4:06PM CST
By Dr. Paul Nunzio De Santis (Pharm.D.) Entry: $9.86 10/2/14 Take Profits: $14.45 11/12/14 Hold 10-20% of profits into event for M&A upside. Achillion (NASDAQ: ACHN ) has been a stellar performer since we wrote about it on October 2nd- up...
ACHN: 13.31 (-0.01), MRK: 59.89 (+0.43), ABBV: 66.05 (+1.01)

Achillion Pharmaceuticals (ACHN) Stock Rises on Positive Hepatitis C Drug Results
at The Street - Wed Nov 12, 10:57AM CST
Shares of Achillion Pharmaceuticals (ACHN) continued to rise Wednesday after the company reported encouraging interim results from a Phase II study of its hepatitis C drug ACH-3102.
ACHN: 13.31 (-0.01)

Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Nov 12, 7:48AM CST
Companies like AbbVie (ABBV), Gilead (GILD) and Achillion (ACHN) had a strong presence at the annual Liver Meeting.
VRTX: 111.04 (-0.58), GILD: 103.71 (+3.27), ACHN: 13.31 (-0.01), DNDN: 0.13 (-0.02), AMGN: 162.24 (+3.10), ABBV: 66.05 (+1.01), REGN: 413.22 (+13.57)

This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success
Todd Campbell, The Motley Fool - Motley Fool - Wed Nov 12, 7:43AM CST
Source: Gilead Sciences. Developing drugs that help established blockbusters work better is a major trend in biotechnology. It's a lower-stakes game because drug developers only need to show that their products can improve upon existing therapies,...
GILD: 103.71 (+3.27), ACHN: 13.31 (-0.01), MRK: 59.89 (+0.43)

Most active Nasdaq-traded stocks
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
FB: 74.34 (+0.10), ACHN: 13.31 (-0.01), DNDN: 0.13 (-0.02), CMCSK: 54.21 (+0.22), ARCP: 8.82 (+0.09), ZNGA: 2.71 (-0.04), MSFT: 48.74 (-0.72), INTC: 34.71 (+0.47), GRPN: 7.37 (-0.20), CMCSA: 54.42 (+0.27), AAPL: 115.47 (+1.48), CSCO: 26.59 (+0.12)

Achillion Jumps on Encouraging Data on its HCV Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 4:10PM CST
Shares of Achillion Pharmaceuticals (ACHN) soared over 27% after the company reported encouraging interim results on ACH-3102.
JNJ: 108.83 (+0.53), GILD: 103.71 (+3.27), ACHN: 13.31 (-0.01), AMAG: 35.34 (+0.58)

Why Is Gilead Always Holding The Ace? A Prediction Of The Future HCV Market And What Analysts Aren't Talking About
Pharma Doc - Seeking Alpha - Tue Nov 11, 10:13AM CST
No matter when you've followed Gilead (NASDAQ: GILD ) over the past decade, they always seem to be holding the ace. Whether in the HIV arena or now in HCV, the Gilead management is always one step ahead and is planning to dominate its market. Gilead...
GILD: 103.71 (+3.27), ACHN: 13.31 (-0.01), MRK: 59.89 (+0.43), ABBV: 66.05 (+1.01), BMY: 58.70 (+0.27)

Gilead presents Harvoni data
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 10:03AM CST

JNJ: 108.83 (+0.53), GILD: 103.71 (+3.27), ACHN: 13.31 (-0.01), CNAT: 7.07 (-0.05), MRK: 59.89 (+0.43), RGLS: 18.12 (+1.27), ABBV: 66.05 (+1.01), BMY: 58.70 (+0.27), ENTA: 43.70 (-0.27)

AbbVie presents HCV/HIV and liver transplant HCV data
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 9:07AM CST

JNJ: 108.83 (+0.53), GILD: 103.71 (+3.27), ACHN: 13.31 (-0.01), CNAT: 7.07 (-0.05), MRK: 59.89 (+0.43), RGLS: 18.12 (+1.27), ABBV: 66.05 (+1.01), BMY: 58.70 (+0.27), ENTA: 43.70 (-0.27)

Merck presents data from its investigational HCV combo
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 8:37AM CST

JNJ: 108.83 (+0.53), GILD: 103.71 (+3.27), ACHN: 13.31 (-0.01), CNAT: 7.07 (-0.05), MRK: 59.89 (+0.43), LGND: 54.59 (-2.36), RGLS: 18.12 (+1.27), ABBV: 66.05 (+1.01), BMY: 58.70 (+0.27), ENTA: 43.70 (-0.27)

Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver
PR Newswire - Tue Nov 11, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for ACHN, CLDX, KNDI, ILMN and AMD.
KNDI: 14.74 (+0.57), AMD: 2.65 (-0.02), ACHN: 13.31 (-0.01), CLDX: 17.72 (-0.53), ILMN: 189.85 (+6.94)

Gilead presents data from three HCV drug combo studies
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 8:05AM CST

JNJ: 108.83 (+0.53), GILD: 103.71 (+3.27), ACHN: 13.31 (-0.01), CNAT: 7.07 (-0.05), LGND: 54.59 (-2.36), RGLS: 18.12 (+1.27), ABBV: 66.05 (+1.01), BMY: 58.70 (+0.27), ENTA: 43.70 (-0.27)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Steady Income Boosts FHLBank Boston's Growth Q3 2026

Updated Category News Views 50

The Federal Home Loan Bank of Boston dropped their third-quarter results for 2026 like a hot smokestack, and let me tell you, it's a mixed bag of cautious optimism and steady progression. It's essentially proof that slow and steady might just win the race—or at least keep you in the running. Stable and Steady Headway Taking a peek under the hood, FHLBank Boston made a...

Continue Reading
Podcast Giants Converge in Tennessee for POD U Summit

Updated Category News Views 80

Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...

Continue Reading
Dimora Medical Boosts Advanced Wound Care at HS Conference

Updated Category News Views 90

Empowering the HS Community with Innovations Look, if you’ve walked a mile in someone else's shoes—particularly ones dealing with hidradenitis suppurativa (HS)—you’d know what a relentless grind managing those exuding wounds can be. Dimora Medical, known for navigating the tricky territory of wound care, threw its hat into the ring at the HS Connect Empower...

Continue Reading
Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 68

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 76

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Cowfest 2026 Delighted by Frederick's Flying Cows

Updated Category News Views 40

Moo-ving Towards a New Record Alright, listen up. This fall, there's a bovine spectacle coming to Maryland that's more than just a trip down to the fairgrounds—it's Cowfest 2026, baby! Now, if you're scratching your head thinking this is just another seasonal shindig, you're underestimating what's mooing across Frederick County. The Flying Cows are ready to take the...

Continue Reading
Gemmy's Orchestra of Lights Op. 2 Unveils New Show

Updated Category News Views 6

Jazzing Up the Holidays with Gemmy's Latest Innovation Just when you thought holiday displays couldn't get more extravagant, along comes Gemmy with its latest wonder—the Orchestra of Lights™ Op. 2. Exclusively hitting Lowe's shelves, this isn't your average set of twinkling bulbs. It's an all-out sensory assault, mixing tunes straight out of yuletide hit lists with...

Continue Reading
Hyperliquid Expands Stock Buyback to $100 Million

Updated Category News Views 71

Diving Into Hyperliquid's $100 Million Bold Move Let’s cut through the corporate fluff—Hyperliquid Strategies Inc. just cranked up their stock repurchase program to a cool $100 million. Yep, that’s right—the brain trust behind NASDAQ:PURR has pulled out the checkbook to buy more of its own shares. This decision, unveiled on October 23, 2026, is like tossing a...

Continue Reading
A Game-Changer for Pediatric Diabetes: Novo's Awiqli®

Updated Category News Views 14

Breaking Through the Diabetes Treatment Wall From where I'm sitting, breakthrough approvals like Novo's Awiqli® hit the healthcare landscape with all the subtlety of a freight train. The FDA's green light for Awiqli® as the first once-weekly insulin for kids aged 10 and over with type 2 diabetes is a monumental shift in the treatment paradigm. We're talking about...

Continue Reading
Violet PR's Big Wins Hint at Industry Strategies

Updated Category News Views 32

A Shining Night in Morristown Picture Violet PR's team on top of the world, right there in Morristown, getting the accolades every agency dreams of—five awards from PRSA-NJ. It's not just an ego trip, either. This is about setting a high bar in the world of strategic communications, and they're flaunting their ability to drive growth and innovation in the economic...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Achievements at the 7th China International Import Expo

Updated Category News Views 143

Successful Conclusion of the 7th China International Import Expo The 7th China International Import Expo (CIIE) has recently concluded, marking a significant milestone in enhancing global trade connections. This remarkable event attracted a multitude of exhibitors and participants from diverse countries, celebrating an array of business opportunities and partnerships. The...

Continue Reading
Pixelworks Invites Shareholders to Revote on Key Proposal

Updated Category News Views 140

Pixelworks Announces Rescheduled Meeting for Shareholders Pixelworks, Inc. (NASDAQ: PXLW), a leader in innovative video and display processing solutions, is reaching out to its valued shareholders regarding the important upcoming Special Meeting. This reconvened meeting represents a crucial opportunity for shareholders to vote on Proposal 1, which aims to authorize the...

Continue Reading
Colombia Reopens Beef Trade with the U.S. Amid Bird Flu Concerns

Updated Category News Views 63

Colombia Rescinds Import Ban on U.S. Beef Amid Bird Flu Concerns Colombia has recently taken a major step by lifting its ban on beef imports from the United States. This decision comes after reports of bird flu found in U.S. dairy cows. A source from the U.S. Department of Agriculture has confirmed that trade can now resume. The Trade Impact of Bird Flu This decision by...

Continue Reading
Anticipating Veru's Earnings: Key Insights for Investors

Updated Category News Views 197

Understanding Veru's Upcoming Earnings Release Veru (NASDAQ: VERU) is preparing to share its quarterly earnings report soon, and anticipation is building among investors. As the company gears up for this announcement, it’s crucial for stakeholders to gather insights on what to expect. Analysts' Expectations for Earnings Projected Earnings Per Share (EPS) Analysts are...

Continue Reading
Veolia Expands Water Technology Strategy for Future Growth

Updated Category News Views 173

Veolia’s Ambitious Growth in Water Technologies Veolia has announced a bold strategy to enhance its role in water technologies, reflecting its commitment to addressing global challenges. With the increasing importance of sustainable resource management, the company is setting its sights on a vibrant market projected to be worth around €220 billion, growing at a rate...

Continue Reading